 I. To estimate the maximally tolerated dose of fludarabine that can be combined with 131I-anti-CD20 iodine I 131 tositumomab delivering 27Gy to critical normal organs followed by autologous or syngeneic transplantation in patients 60 years of age with relapsed B-NHL. 